GENE ONLINE|News &
Antibody Drug Conjugates: The Next Big Thing in Cancer Therapy?
Cancer is the second most common cause of global deaths, accounting for approximately 10 million per year. It is estimated that in 2021 there will be an additional 1.9 million new cases in the US alone, with around 600,000 deaths. Cancer therapy has improved over the last decade, thanks to technological advances and research Progress. Here we take a closer look at one such significant advance, the antibody conjugated drugs (ADCs).
What are ADCs?
GO Prime with only $1.49 now
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
